RemeGen

Public

Yantai, ShandongHealthcarehttps://remegen.com/

Last Round

Follow-on Offering

Mar 31, 2022

Total Funding Raised

$1.03B

Company Overview

RemeGen is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative biologic drugs for the treatment of autoimmune, oncology, and ophthalmic diseases.

Sector

Healthcare

AI Layer

Application

Keywords

biopharmaceuticalbiotechantibody-drug conjugateADCfusion proteinautoimmune disease treatmentoncologydrug discoveryclinical trialsbiologicsprotein engineeringpharma licensingAI-driven drug discoveryin-silico drug design

RemeGen Comps

Public and private peers based on sector, stage, and business model.

RemeGen comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RemeGen Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Follow-on Offering	Mar 31, 2022
IPO Announced	Nov 9, 2020
Private Equity	Mar 16, 2020

View all Funding Rounds

RemeGen Investors

Notable investors and investment history

RemeGen investors
Investor	Rounds
Loyal Valley Capital	Private Equity
Lake Bleu Capital	IPO, Private Equity
Huatai International	IPO
Hillhouse Capital Group	IPO
OrbiMed	Private Equity, IPO
Counterpoint Global (Morgan Stanley)	IPO
Janchor Partners	Private Equity

View all Investors

RemeGen Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RemeGen Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersYantai, Shandong

Employee Range3

Year Founded2008

Last FundingMar 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.